Ignyta Appoints Dr. Tom Huizinga to Scientific Advisory Board

Published: Mar 20, 2013

Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, announced today the appointment of Professor Tom Huizinga, Chairman of the Department of Rheumatology at Leiden University Medical Center (LUMC), to its Scientific Advisory Board.

Back to news